INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,551,938 | -13.6% | 112,332 | +11.4% | 0.69% | +0.9% |
| Q2 2023 | $4,111,929 | +4348.7% | 100,832 | +3965.8% | 0.69% | +3711.1% |
| Q1 2023 | $92,430 | -96.3% | 2,480 | -96.5% | 0.02% | -96.3% |
| Q4 2022 | $2,490,448 | -37.6% | 71,380 | 0.0% | 0.48% | -38.8% |
| Q3 2022 | $3,994,000 | +8.1% | 71,380 | 0.0% | 0.79% | +5.6% |
| Q2 2022 | $3,695,000 | -29.6% | 71,380 | -1.1% | 0.74% | -20.0% |
| Q1 2022 | $5,247,000 | -38.0% | 72,200 | +0.8% | 0.93% | -26.9% |
| Q4 2021 | $8,466,000 | +0.3% | 71,600 | +13.8% | 1.27% | +81.5% |
| Q3 2021 | $8,438,000 | +263.7% | 62,900 | -48.9% | 0.70% | +207.9% |
| Q3 2016 | $2,320,000 | +58.3% | 123,159 | 0.0% | 0.23% | +51.0% |
| Q2 2016 | $1,466,000 | – | 123,159 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |